The FDA review – which is due to be completed by 28th September – revolves around the results of the HERCULES trial which ...
DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to ...
General Electric (GE +0.7%) Chairman Jeffrey Immelt says he will remain on Pres. Trump's American Manufacturing Council.
Severe weather moved through Mississippi with violent tornadoes, destructive winds and hail on Saturday. Six people were confirmed dead, and Gov. Tate Reeves declared a state of emergency.
Hosted on MSN24d
Take-at-home tablet for MS approved for wider NHS rolloutThe health service is thought to be the first in Europe to widely rollout cladribine, also known as Mavenclad and made by Merck. It has been approved by the National Institute for Health and Care ...
Merck KGaA’s Mavenclad (cladribine) tablets have been recommended by the National Institute for Health and Care Excellence (NICE) to treat a broader group of multiple sclerosis (MS) patients. The ...
Merck has opened a new manufacturing plant in Durham, NC which will make HPV vaccines, including its quadrivalent vaccine Gardasil and nine-valent vaccine Gardasil 9 … ...
A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding lawsuits accusing the drugmaker of failing to warn consumers its Gardasil ...
The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results